CN116179561B - Application of Braket black cattle skeletal muscle differentiation regulation gene LOC112441863 - Google Patents
Application of Braket black cattle skeletal muscle differentiation regulation gene LOC112441863 Download PDFInfo
- Publication number
- CN116179561B CN116179561B CN202211630814.4A CN202211630814A CN116179561B CN 116179561 B CN116179561 B CN 116179561B CN 202211630814 A CN202211630814 A CN 202211630814A CN 116179561 B CN116179561 B CN 116179561B
- Authority
- CN
- China
- Prior art keywords
- cattle
- gene
- black
- skeletal muscle
- muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000283690 Bos taurus Species 0.000 title claims abstract description 81
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 45
- 230000004069 differentiation Effects 0.000 title abstract description 21
- 210000002027 skeletal muscle Anatomy 0.000 title abstract description 8
- 230000033228 biological regulation Effects 0.000 title description 2
- 230000001737 promoting effect Effects 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 31
- 241000700605 Viruses Species 0.000 claims description 17
- 239000013598 vector Substances 0.000 claims description 11
- 241000701161 unidentified adenovirus Species 0.000 claims description 7
- 241000713666 Lentivirus Species 0.000 claims description 4
- 239000013612 plasmid Substances 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 3
- 210000001082 somatic cell Anatomy 0.000 claims description 3
- 241000702421 Dependoparvovirus Species 0.000 claims description 2
- 239000002502 liposome Substances 0.000 claims description 2
- 230000014509 gene expression Effects 0.000 abstract description 33
- 210000001087 myotubule Anatomy 0.000 abstract description 32
- 230000035755 proliferation Effects 0.000 abstract description 18
- 235000013372 meat Nutrition 0.000 abstract description 15
- 210000002363 skeletal muscle cell Anatomy 0.000 abstract description 12
- 235000015278 beef Nutrition 0.000 abstract description 10
- 230000001105 regulatory effect Effects 0.000 abstract description 10
- 210000003854 type 2 muscle cell Anatomy 0.000 abstract description 9
- 238000009395 breeding Methods 0.000 abstract description 8
- 230000001488 breeding effect Effects 0.000 abstract description 8
- 230000012010 growth Effects 0.000 abstract description 8
- 230000006870 function Effects 0.000 abstract description 4
- 238000002474 experimental method Methods 0.000 abstract description 3
- 210000000663 muscle cell Anatomy 0.000 abstract description 2
- 108020005198 Long Noncoding RNA Proteins 0.000 description 16
- 210000003205 muscle Anatomy 0.000 description 15
- 238000000034 method Methods 0.000 description 12
- 239000003550 marker Substances 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 8
- 238000012163 sequencing technique Methods 0.000 description 7
- 239000006228 supernatant Substances 0.000 description 7
- 239000012634 fragment Substances 0.000 description 6
- 210000002966 serum Anatomy 0.000 description 5
- 210000001519 tissue Anatomy 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000003321 amplification Effects 0.000 description 4
- 230000004186 co-expression Effects 0.000 description 4
- 238000010219 correlation analysis Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000010195 expression analysis Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 210000003098 myoblast Anatomy 0.000 description 4
- 238000003199 nucleic acid amplification method Methods 0.000 description 4
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 108091046869 Telomeric non-coding RNA Proteins 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 238000010276 construction Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000009826 distribution Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000011159 matrix material Substances 0.000 description 3
- 230000002018 overexpression Effects 0.000 description 3
- 210000003875 slow muscle fiber Anatomy 0.000 description 3
- 238000010257 thawing Methods 0.000 description 3
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 101000635885 Homo sapiens Myosin light chain 1/3, skeletal muscle isoform Proteins 0.000 description 2
- 101000958755 Homo sapiens Myosin-4 Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 102100030740 Myosin light chain 1/3, skeletal muscle isoform Human genes 0.000 description 2
- 102100038302 Myosin-4 Human genes 0.000 description 2
- 241000219053 Rumex Species 0.000 description 2
- 210000001142 back Anatomy 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 230000007910 cell fusion Effects 0.000 description 2
- 239000006285 cell suspension Substances 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 230000002596 correlated effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000007918 intramuscular administration Methods 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 108020004999 messenger RNA Proteins 0.000 description 2
- 230000037257 muscle growth Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000009897 systematic effect Effects 0.000 description 2
- 101100439046 Caenorhabditis elegans cdk-2 gene Proteins 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 108050006400 Cyclin Proteins 0.000 description 1
- 102100024810 DNA (cytosine-5)-methyltransferase 3B Human genes 0.000 description 1
- 101710123222 DNA (cytosine-5)-methyltransferase 3B Proteins 0.000 description 1
- 101100520033 Dictyostelium discoideum pikC gene Proteins 0.000 description 1
- 208000035240 Disease Resistance Diseases 0.000 description 1
- 235000012571 Ficus glomerata Nutrition 0.000 description 1
- 244000153665 Ficus glomerata Species 0.000 description 1
- 101001023043 Homo sapiens Myoblast determination protein 1 Proteins 0.000 description 1
- 101000779418 Homo sapiens RAC-alpha serine/threonine-protein kinase Proteins 0.000 description 1
- 241000533950 Leucojum Species 0.000 description 1
- VAYOSLLFUXYJDT-RDTXWAMCSA-N Lysergic acid diethylamide Chemical compound C1=CC(C=2[C@H](N(C)C[C@@H](C=2)C(=O)N(CC)CC)C2)=C3C2=CNC3=C1 VAYOSLLFUXYJDT-RDTXWAMCSA-N 0.000 description 1
- 108091060568 Mir-133 microRNA precursor family Proteins 0.000 description 1
- 102100035077 Myoblast determination protein 1 Human genes 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 102000009339 Proliferating Cell Nuclear Antigen Human genes 0.000 description 1
- 238000003559 RNA-seq method Methods 0.000 description 1
- 238000011529 RT qPCR Methods 0.000 description 1
- 108010087230 Sincalide Proteins 0.000 description 1
- 238000012167 Small RNA sequencing Methods 0.000 description 1
- 102100038803 Somatotropin Human genes 0.000 description 1
- 108050007673 Somatotropin Proteins 0.000 description 1
- 102000040945 Transcription factor Human genes 0.000 description 1
- 108091023040 Transcription factor Proteins 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 238000012098 association analyses Methods 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000031018 biological processes and functions Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 244000309466 calf Species 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 238000010370 cell cloning Methods 0.000 description 1
- 238000010609 cell counting kit-8 assay Methods 0.000 description 1
- 238000001516 cell proliferation assay Methods 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000009025 developmental regulation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000012757 fluorescence staining Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 210000005003 heart tissue Anatomy 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 108091023685 miR-133 stem-loop Proteins 0.000 description 1
- 108091043249 miR-135-1 stem-loop Proteins 0.000 description 1
- 108091064876 miR-135-2 stem-loop Proteins 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009756 muscle regeneration Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000003365 myofibril Anatomy 0.000 description 1
- 230000004070 myogenic differentiation Effects 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 108091027963 non-coding RNA Proteins 0.000 description 1
- 102000042567 non-coding RNA Human genes 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 238000001543 one-way ANOVA Methods 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000036961 partial effect Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000006798 recombination Effects 0.000 description 1
- 238000005215 recombination Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000009711 regulatory function Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 231100000161 signs of toxicity Toxicity 0.000 description 1
- IZTQOLKUZKXIRV-YRVFCXMDSA-N sincalide Chemical compound C([C@@H](C(=O)N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(N)=O)NC(=O)[C@@H](N)CC(O)=O)C1=CC=C(OS(O)(=O)=O)C=C1 IZTQOLKUZKXIRV-YRVFCXMDSA-N 0.000 description 1
- 210000000419 skeletal muscle satellite cell Anatomy 0.000 description 1
- 230000022379 skeletal muscle tissue development Effects 0.000 description 1
- 230000004096 skeletal muscle tissue growth Effects 0.000 description 1
- 230000012488 skeletal system development Effects 0.000 description 1
- 210000001189 slow twitch fiber Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000012096 transfection reagent Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000009128 xihuang Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15041—Use of virus, viral particle or viral elements as a vector
- C12N2740/15043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Rheumatology (AREA)
- Virology (AREA)
- Cell Biology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention belongs to the technical field of biological breeding, and particularly relates to application of a skeletal muscle differentiation regulating gene LOC112441863 of Bulkhead black cattle. The Brachite black cattle gene LOC112441863 has the functions of regulating proliferation, differentiation and expression of bovine skeletal muscle cells and/or promoting generation of type II muscle fibers of cattle. Can be used for regulating proliferation and differentiation expression of bovine skeletal muscle cells and promoting generation of bovine type II myofibers. Experiments prove that LOC112441863 can regulate proliferation and growth of skeletal muscle of Bulkhead black cattle and can also regulate type II myofiber generation. LOC112441863 can influence proliferation and growth of muscle cells of the Brakeat black cattle, thereby influencing growth of meat quality, and individuals with high LOC112441863 content should be selected as beef cattle with high meat yield in breeding, so that a new direction is provided for breeding of high-quality Brakeat beef cattle.
Description
Technical Field
The invention belongs to the technical field of biological breeding, and particularly relates to application of a skeletal muscle differentiation regulating gene LOC112441863 of Bulkhead black cattle.
Background
In livestock production, the meat producing performance of animals is an important economic indicator, and activation, proliferation, migration, arrangement, fusion and differentiation of skeletal muscle satellite cells to form contractile and beating multinuclear myotubes is critical for myogenesis. Therefore, research on the muscle growth and development regulation network from different layers plays a very important guiding role in understanding and improving the meat production performance of animals.
The Bulkhead black cattle is a new germplasm of high-quality beef cattle, and is a good germplasm resource obtained by improving local Ruxi yellow cattle and Bohai sea black cattle through combining modern biotechnology such as somatic cell cloning and the like with a conventional breeding hybridization method. The hybrid germplasm fully shows hybrid vigor, maintains beef quality characteristics and partial appearance characteristics, and obtains physiological characteristics of Luxi cattle and Bohai black cattle adapting to local environment and geographic conditions. The beef has the characteristics of good meat quality, typical marble patterns, also called snowflake meat, tenderness and succulent, contains rich proteins, has amino acid composition which is more similar to the needs of human bodies than pork, can improve the disease resistance of organisms, has the functions of nourishing cardiac muscles and enhancing resistance, contains rich iron, has very low content of saturated fatty acid in intramuscular fat, has high content of unsaturated fatty acid, has unique flavor, fresh and tender meat quality and good taste, contains rich trace elements and CoQ10, and is a new high-quality beef germplasm which is not available in beef germplasm resources in China.
Long non-coding RNA, abbreviated as lncRNA, refers to non-coding RNA that is greater than 200 nucleotides in length. LncRNA has very important regulatory functions, and almost participates in various biological processes and pathways, and is closely related to the occurrence and development of various diseases, so that the LncRNA becomes a research hot spot and an important point in the past few years and in the future. Several muscle-specific lncRNAs that control muscle gene expression have been reported to date, including muscle-specific linc-MD1. Recently, a LncRNA-FKBP1C has been reported to regulate muscle growth by inhibiting DNMT3B during myogenic differentiation and muscle regeneration. In bovine myoblasts LncYYW positively regulate the expression of the growth hormone 1 (GH 1) gene and its downstream genes AKT1 and PIK3 CD. Linc-MD1 proved to be competitive endogenous RNA for miR-133 and miR-135 targets during myoblast differentiation, and these transcription factors activate muscle-specific gene expression, thereby controlling the time of muscle differentiation.
Disclosure of Invention
In order to solve the problems in the prior art, the invention provides an application of LOC112441863 in regulating proliferation and differentiation expression of skeletal muscle cells of Bullet black cattle, and LOC112441863 can regulate proliferation and growth of skeletal muscle of Bullet black cattle and can regulate type II myofiber generation.
In order to achieve the above purpose, the present invention adopts the following technical scheme.
An application of LOC112441863 in the breeding of Brakeet black cattle.
A briKate black bovine gene LOC112441863, said briKate black bovine gene LOC112441863 having a function of regulating proliferation and differentiation expression of bovine skeletal muscle cells and/or a function of promoting bovine type ii myofiber production.
The application of the Brachiensis gene LOC112441863 in regulating proliferation and differentiation expression of bovine skeletal muscle cells; the Braket black bovine gene LOC112441863 can promote proliferation of bovine skeletal muscle cells and inhibit differentiation of bovine skeletal muscle cells.
The Brachiensis gene LOC112441863 is applied to promoting the generation of type II muscle fibers of cattle.
Further, the method of operation of the application is to transfect a vector containing the LOC112441863 mimetic or inhibitor into a target cell.
Further, the vectors are lentiviruses, adenoviruses, adeno-associated viruses, liposomes and plasmids for constructing viruses.
Further, the target cell is selected from somatic cells, fertilized eggs, cell lines of Bullebrand black cattle.
The application is to screen individuals with high LOC112441863 content as beef cattle with high meat yield.
An application of LOC112441863 in regulating proliferation and differentiation of skeletal muscle cells of Bullet black cow is provided.
Advantageous effects
Experiments prove that LOC112441863 can regulate proliferation and growth of skeletal muscle of Bulkhead black cattle and can also regulate type II myofiber generation. LOC112441863 can influence proliferation and growth of muscle cells of the Brakeat black cattle, thereby influencing growth of meat quality, and individuals with high LOC112441863 content should be selected as beef cattle with high meat yield in breeding, so that a new direction is provided for breeding of high-quality Brakeat beef cattle.
Drawings
Fig. 1 is a graph of the histological properties of the muscle fibers of brisket black cattle and ruxi yellow cattle, wherein fig. 1A and 1B are a graph of the fluorescence staining of the transverse and longitudinal cut fast and slow muscles of the muscle fibers (brisket black cattle on top 2 and ruxiyellow cattle on bottom 2) and statistical analysis of the area of the fast/slow muscle fibers, the total area of the fast/muscle fibers, and the total area of the slow/muscle fibers. Fig. 1C and 1D are graphs of the transverse and longitudinal HE staining of muscle fibers (left 2 is briKate black cattle, right 2 is Ruxi yellow cattle) and statistical analysis of the area, diameter, length, density and number of muscle fibers.
FIG. 2 is a LOC112441863 screen, FIG. 2A is a Wen diagram of the final 5810 lncRNAs dataset using four analysis methods (CNCI, CPC, PFAM, CPAT) to determine non-coding transcripts; FIG. 2B is a diagram showing schematically the distribution of differential lncRNA and differential gene Circos; FIGS. 2C and 2D are LOC112441863 and meat quality trait association analysis;
FIG. 3 is an analysis of LOC112441863 expression in different tissues of Bulkhead black cattle and Ruxi yellow cattle;
FIG. 4 is a lentiviral vector;
FIG. 5 shows the efficiency of LOC112441863 adenovirus in infecting cells;
FIG. 6 shows the induction of differentiation of Bullechet black cow myoblasts;
FIG. 7 is an EDU cell proliferation assay;
FIG. 8 shows the detection of a myoblast proliferation differentiation marker gene;
FIG. 9 is a graph showing the effect of LOC112441863 on type II muscle fiber of Bulkhead black cattle, and FIGS. 9A and 9B are type II muscle fiber marker gene assays; FIGS. 9C and 9D are LOC112441863 expression level and marker gene correlation analysis.
Detailed Description
The present invention will be further described with reference to examples and drawings, but the present invention is not limited to the examples.
EXAMPLE 1 measurement of myofiber histological Properties
As a result of performing fast/slow myofluorescence staining on muscle fibers of brisket black cattle and ruxol cattle, as shown in fig. 1A, B, it was found that the ratio of the number of muscle fibers of the fast muscle (red representing fast muscle fiber (type 2))/slow muscle (green fluorescence is slow muscle fiber (type 1)) of brisket black cattle was extremely lower than the ratio data (P < 0.01) of ruxol cattle, and it can be seen from the picture: the Braikite black cattle have more slow muscle fibers and the Ruxi yellow cattle have more fast muscle fibers. There was no significant difference (P > 0.05) in the index of the fast/total muscle fiber area ratio and slow/total muscle fiber area ratio.
According to the results of the dyeing of the muscle fibers HE of the brisket black cattle and the luxi yellow cattle in fig. 1C and 1D, we find that the shape of the muscle fibers of the brisket black cattle is an irregular polygon and the shape of the muscle fibers of the luxiyellow cattle is an irregular ellipse when the muscle fibers are transected; when the muscle fibers are slit, the intramuscular fat of the Braiki black cattle is more than that of the Ruxi cattle. When the HE staining chart is analyzed by Image J software, the average area of the muscle fiber of the Brachikungunya cattle is found to be significantly higher than that of the Brachikungunya cattle (P < 0.05), the average area of the muscle fiber of the Brachikungunya cattle reaches 5490.22 mu m 2, and the average area of the muscle fiber of the Brachikungunya cattle reaches 4869.00 mu m 2. The muscle fiber density of the muscle fibers of briKate black cattle is significantly higher than that of Ruxi yellow cattle (P < 0.01). There were no significant differences in the indices of myofiber diameter, length and number (P > 0.05).
Example 2LOC112441863 screening
To find lncRNAs modulated by meat quality traits, these lncRNAs have a potential causal contribution to certain specific benefits of skeletal muscle growth and development adaptation, a dataset of lncRNAs differentially expressed by the longissimus brainstorming and Lu Xihuang bovine dorsum was established according to the small RNA sequencing protocol. For the analysis of published datasets (GSM 4904154, GSM4904155, GSM4904156, GSM4904157, GSM4904158, GSM 4904159), four analysis methods (CNCI, CPC, PFAM, CPAT) were used to discriminate the non-coding transcripts as the final 5810 lncRNAs dataset (fig. 2A). Finally 480 differentially expressed lncRNAs were determined. We visually showed the distribution of the differential lncRNA and the differential gene using Circos panels (FIG. 2B), and found that the differentially expressed lncRNA was most distributed on chromosome 9. Wherein the expression level estimation and differential expression analysis employ the following methods:
(1) Expression level estimation
Gene expression levels are generally measured by how much mRNA the gene is transcribed from. The amount of RNA transcribed from each gene is regulated by various factors such as space time, and the amount of mRNA transcribed from the gene varies in individuals at different stages of growth or in different tissues. FPKM is a very effective tool for quantitatively estimating gene expression values using the RNA-Seq technique. FPKM is an abbreviation for FRAGMENTS PER Kilobase per Million MAPPED FRAGMENTS, which is calculated by:
If FPKM (A) is used as the expression quantity of the gene A, F is the number of Fragments which are uniquely compared with the gene A, N is the total number of Fragments which are uniquely compared with the reference gene, L is the length of the exon region of the gene A, the FPKM method can eliminate the influence of the difference of the gene length and the sequencing quantity on the calculated gene expression, and the calculated gene expression quantity can be directly used for comparing the gene expression difference among different samples.
(2) Differential expression analysis
For experiments with biological replicates we used DEseq for differential expression analysis and DEGseq for samples without biological replicates. Comparing the treatment group with the reference group, and selecting genes with |log 2 ratio|not less than 1 and q <0.05 as obvious differential expression screening conditions to obtain 480 differential expression lncRNAs.
With the identification of a panel of lncRNA, we sought to elucidate the potential biological functions of lncRNA in muscle tissue. We identified co-expression modules from transcriptome data. A total of 16 co-expression modules were obtained and 16 colors were assigned for visual differentiation (fig. 2C). In order to evaluate the correlation between each module and 12 meat quality traits (Type I muscle fiber,TypeⅡmuscle fiber,skeletal muscle area(SMA),muscle fiber diameters(MFD),fascicle length,fiber density,muscle fibre number(MFN),Body weight,Body height,dressing percentage,Ribeye weight,ribeye area(RA)), we performed a correlation analysis between the module and the meat quality traits, the correlation analysis adopts a weighted gene co-expression analysis flow, which specifically includes the steps of:
(1) Input data preparation
Reading fpkm the expression matrix, and performing log 2 (x+1) transformation; and finally, transposing the matrix to form a behavior sample and a column in the form of genes.
(2) Judging the data quality, and drawing a systematic clustering tree of samples
Checking the data quality of the sample and the gene, and removing low-quality data; drawing a systematic cluster tree of the sample, and removing if a significant outlier exists; and a PCA diagram can be also made to check the distribution condition of the sample.
(3) Selecting an optimal threshold Power
Selection criteria: r 2 >0.8, slope≡1, select the power value at the inflection point of the R 2 vs. power graph.
(4) Construction of weighted co-expression network (one-step method and fractional method) and identification of gene modules
(5) Association of gene modules and phenotypes: module and phenotype association heatmaps, module and phenotype association boxplot, gene and module, phenotype association scattergrams.
(6) WGCNA map, module correlation display
WGCNA's map TOMplot/Network heapmap plot, which depicts a Topological Overlap Matrix (TOM) between all genes in the analysis, with deeper colors indicating greater correlation between genes;
Eigengene-adjacency-heatmap shows the correlation between gene modules. The "black", "ping", "royalblue" modules with higher correlation to phenotype were chosen for GO analysis.
We found that modules 5 and 16 correlated significantly positively (correlation >0.90, p < 0.001) with SMA, FASCICLE LENGTH and MFN, respectively (fig. 2D). These results indicate that the modules exhibit specific expression of the meat quality trait. When we rank these lncRNAs according to their reactivity (magnitude of effect and statistical significance) to muscle, the lncRNAs that are most reactive to muscle tissue are identified as LOC112441863. Next, the expression level of LOC112441863 was verified on different tissues of Bullet black cattle and Russell yellow cattle, and the PCR reaction system was 25. Mu.L, and 12.5. Mu.LPremix Ex Taq II, 1. Mu.L of upper primer, 1. Mu.L of lower primer, 2. Mu.L of cDNA and 8.5. Mu.L of ddH 2 O. The reaction procedure is: 95; total 304s0ec cycles: 95℃for 5sec and 62℃for 30sec. Three replicates were performed for each sample. As shown in FIG. 3, the result of the one-way analysis of variance using SPSS 20.0 software shows that LOC112441863 is significantly different in the dorsi longus and heart tissues of Bullet black cattle and Russell yellow cattle (P > 0.01). Table 1 shows LOC112441863 and marker gene primer information.
Table 1 qPCR primers for genes
Example 3LOC112441863 lentiviral construction
The pAdEasy-EF1-MCS-CMV-EGFP (EcoRI MCS) vector map is shown in FIG. 4, the target fragment LOC112441863 is connected with the vector after PCR amplification of the target fragment, the connection reaction solution is reacted for 30min at 50 ℃, and the reaction solution is placed on ice for 5min and immediately converted. Sequencing after bacterial liquid PCR identification, and sequencing results show that: the sequencing result was consistent with the target sequence, as shown in Table 2, and the construction of the target plasmid was successful. Cells were transfected after adenovirus vector recombination, and LOC112441863 sequence information and vector sequencing result sequence information are shown in table 2.
TABLE 2LOC112441863 sequence information and sequencing results
Gene name | Sequence information |
LOC112441863 | SED ID NO:1 |
Vector sequencing | SED ID NO:2 |
Adenovirus packaging and purification: the day before transfection, 293 cells were inoculated in 60mm dishes in DMEM+10% Hyclon foetal calf serum and incubated overnight at 37℃in an incubator containing 5% CO 2. When the cells grow to 70-80% of the basal area, taking adenovirus vector linearization plasmid which is successfully recombined, carrying out transfection by Lipofiter TM transfection reagent, and replacing fresh cell culture solution after 6 hours of transfection. Cells were observed daily for signs of toxicity. The toxic phenomenon is that cells become larger and round, are grape-shaped, and begin to appear as obvious plaques. And (5) taking the virus out after most of the cells are diseased and fall off from the bottom. All cells and culture medium in 60mm dishes were collected in 15ml centrifuge tubes.
The thermostat water bath was opened to 37℃and the 15ml centrifuge tube was repeatedly freeze-thawed three times in a liquid nitrogen and 37℃water bath. Centrifugation at 3000rpm for 5 min, collecting the virus-containing supernatant, and discarding the pellet. The supernatant was the first virus seed (P1) of the control virus and was used as the seed for subsequent amplification of a large number of viruses.
2Ml of cells (cell density of 90% or more) from a10 cm cell culture dish were collected from the P1 virus supernatant (about 3 ml). The remaining virus supernatant is put into a frozen tube with external rotation and reserved at-80 ℃ and is used as the virus seed.
After two days of virus amplification, all cells fall off the bottom surface to be subjected to virus collection (P2), the cells and the culture solution are taken into a 15ml centrifuge tube together, and the cells are subjected to freeze thawing for three times according to the freeze thawing method, and the supernatant is taken for next generation amplification or stored at the temperature of minus 80 ℃. The virus amplification and virus collection are repeated in each generation.
Inoculating 4×10 6 293 cells into each 75cm 2 square bottle, inoculating 6 75cm 2 culture bottles, culturing overnight, and when the cells grow to 90%, inoculating the P2 generation virus (except for taking a small amount of virus retaining seeds) into the culture bottles completely, observing under a microscope after 24 hours to find 60% cytopathy, and completely treating the cells after 46 hours. After harvesting the diseased cell suspension, centrifuging at 2000rpm for 5min, discarding the supernatant, adding 6ml of ST buffer (culture solution+10% serum+2.5% glycerol), mixing votex, freezing and thawing three times between liquid nitrogen and 37 ℃, centrifuging at 3000rpm for 5min, and taking the supernatant as the third generation virus (P3).
The adenovirus was purified and then quality tested, and the titer results are shown in Table 3.
TABLE 3 titer results
HBAD-EGFP overexpression control | 3.16*1010PFU/mL |
HBAD-Adeasy-LOC112441863-Null-EGFP | 1.99*1010PFU/mL |
Example 4 effect of LOC112441863 on skeletal muscle cell differentiation and proliferation of Bullechet black cattle
And (3) taking hind limb muscles of the 5-month-old Bulleyan black cow fetus as a source to obtain cow primary cells through isolated culture. When the cells were grown to 80% confluence, in vitro myogenic induction differentiation was performed by adding DMEM medium containing 2% horse serum, the cells were collected, the cell suspension concentration was adjusted with complete medium, and the cells were divided into 6-well plates, 2×10 5 cells/well, 2mL per well, and cultured in a 5% CO 2 incubator at 37 ℃ for 24 hours, and infection blank (blank), LOC112441863 over-expression lentivirus (mimic) and LOC112441863 over-expression lentivirus negative control (NC inhibitor), and the infection efficiency was as shown in fig. 5. After 48 hours of further culture, the medium was replaced with a high-sugar DMEM medium containing 2% horse serum, and the culture was continued. After transfection, cell morphology was observed at 2d,3d,4d,5d, and cell proliferation rates were measured at 0h, 24h, 48h, 72 hEdU.
The morphology of the cells treated differently 2-5 days after transfection is shown in FIG. 6: cell fusion phenomenon starts to appear after 2 days of induced differentiation by using 2% horse serum, and compared with the blanc group, the LOC112441863mimic group has more cell fusion quantity; at 3 days, a large number of myotubes are formed by the LOC112441863mimic group and the blanc group, so that the cell length is obviously increased; at 4 days and 5 days, the LOC112441863mimic group myotubes had increased diameter and no significant difference in number compared to the blank group. LOC112441863 can be seen to promote skeletal muscle cell differentiation in briKate black cattle.
The result of Edu method for detecting the cell proliferation rate is shown in FIG. 7: LOC112441863mimic significantly reduced the number of Edu positive cells compared to the blank group (P < 0.01), and in summary, both CCK-8 and EdU results indicate that LOC112441863 inhibits the proliferation of briketjen skeletal muscle cells.
QRT-PCR was performed on the expression levels of proliferation marker genes (CDK 2, PCNA) and differentiation marker genes (MYOD 1, MYH 1) by the method of example 1, and the results are shown in FIG. 8. The results show that LOC112441863mimic significantly increases the expression level of differentiation marker gene (P < 0.01), significantly inhibits the expression level of proliferation marker gene (P < 0.01), and that LOC112441863 promotes skeletal muscle cell differentiation and inhibits proliferation.
Example 5 influence of LOC112441863 on type II muscle fiber of Bullet black cattle
Re-analysis of Hematoxylin and Eosin (HE) stained sections showed that the dorsum longus muscle of Lu Xiniu consisted mainly of type II muscle fibers. The analysis result of LOC112441863 tissue expression shows that compared with a Blacket black cow sample, LOC112441863 has higher expression amount in the longus muscle of the back of the Rumex flavus, and the Rumex flavus tissue mainly consists of type II muscle fibers, which indicates that LOC112441863 can participate in regulating type II muscle fibers.
The expression level of type II myofiber marker genes (MYL 1, MYH 4) was examined by referring to the method in example 1, as shown in FIGS. 9A, 9B. It can be seen that LOC112441863mimic increases the expression level of the marker gene very significantly (P < 0.001), and LOC112441863 is presumed to promote type ii myofibril formation. Next, correlation analysis is performed on the expression level of LOC112441863 and the expression levels of MYH4 and MYL1, as shown in fig. 9C and 9D, and the result shows that LOC112441863 is positively correlated with the expression levels of MYH4 and MYL1, and further illustrates that LOC112441863 promotes type ii myofiber generation.
Sequence listing
SED ID NO: the sequence 1 is:
CTACCACGTGTGGTCAGCTGGAGAGGGCAGTGCCCAGGGAGCTCAGAGCTGCATGCACAGTGTCCCGAGTGCCAGATCAGAAGGGTGAGGAGACGTGGATCAGGCTTCCCCGGCCATCAGACACTGGGGGTGTTGGGGGTCCCAGGAGCACCCCATACCCCAGGAAGTGCTGCTTTCTGAGGGAAAGAGCCCTTGCTGAGGAGTCCAAGGGGCTCTGGTCCCACTCAGCAGCCTGGGACCCCGGGGCCTCAGGTGTCTCTGCCGCTATCAGATCCCTCCTCCTTGGAGTCAACAAGAACCAGCGTGCAGCCAGCTCTGGGCTTCGCAGGGGTTCAGTGGTAAAGAATCTGCCTGCAATGCAGGAGACGTGGGTTCGATCCCTGGGTCGGGAAGATTCCCTGGAGAAGGAAATGGCAACCCACTGCAGTATTCTTGCCTGGAGAATCCCATGGACAGAGGAGTCCAGCGGGCTACAGTCCATGCGGTTGCAAAAGAGTTGAATGTGACTTAGCAACTGAGCACCAACAACAGCCAGTTCTGCACAGACTGTATGACCTCGGGGAAGATGCTGGGCTGTTCCCCACTGGCCCTTCCAGCTCTGTGCCCCGGAAGCTGGCCTAAAGCTGCACTGGTGGGCTCCCTCACCGTCTGGCTTCAGCTGGACGAGAGGAGAATGTGGCCTGGATGCCCTCCCTGCTGGACTGGGGCTTGGCAGTGGCAGATGTCTCTCCCAGAGGCCCTTGGCTCCTCGTGGGCAGCTGTCTCCTCCGGTTACGGCACATACCAGATCCCAGAGGCCTAGAGCGGCAACAGCCCCCTGCTTTGCAGGCTCTGGGTGCCCACCGGCCCTTGTGGGTCCCCCAACTCTGCTCACACGTCTGTACATTGTCTTTTCATCAAGCCCTTCAGCCCCTGTTCTGCATGTGTCTTCTGCCTCTGAACTGCCTGCAATATCACTGAACCCTCTTAGCTTGTTTCCCCATCCTTCTGCTGGGGACCATGATGACATCTGCCTCTAGAAGCTGGAAGAGACAAGGAAACGGATTCTTTCCTAGAGTGATGCAAAGGAACGCTGCTTTGTAGACACCTTGGTTTAGCCCAGACACTGATTTTGGAGATCTGACCTCTGGGCTGTAAGAAGATAAACTTTCGTTGTTTTAAGCCACAACGTTTGTGGCCATTTGTTACAGCGGCCATAGGATACTGCTACACGGGTCCAGGCCCCAGATAAGCAGTGACTGTAATAAATTCTGGGCTCTTCCCCAGCTCCAGCTGAACATTCCAGGAGCAGCTGCTCAGGGGCAACCTGACCGTGACCTCCCAGAACCTCAGTGTCTTCATTTTGGCCTAGGAGGCACATGTGTTTTTTTTTTTTTTCCCCTGCCAGGGTGAAATGCTGACAACAAATTATGTCTCAAGGGTTTCAGACTCCAGTGTTATCAGGAGCCTGAGTAACATGGCAAGTCGCCTGAGTGAGTGGGATGGTGTGAAGCAGTGGGGAGTGGTGGGCCTGTGGCAAACTGGAGAACTCACACCTTGCTTAAAGACATCAACTTTACGACTTCCCCAGCTTCCCTGGTGGCTCAGATGGTAAAGTGTCTGCCTGCAATGCGAGAGACCTGGGTTCGATCCCTGGGTGGAGAAGATCCCCTGGAGAAGGAAATGGAAACCCACTCCAGTACTCTTGCCTGGAAAATTCCATGGACGGAGGAGCCTGGTAGGCTACAGTCCATGGGGTTGCAAAGAGTCAGACAAGACAAAGCGAGTTTGCTTTCACTTTAGGACTTCCCTGGTGGTCCAGTGGTTGAGAATCCACCTGCCAATGGAGGGGACATGGGTTCGATCCCTGGTCAGGGAAGACCCGTGAGGCAGCTGGCCTGCGCACCACCACCACTGAGCCCACGCTCTGGAGCCTGAGCGTTTCAACAGCTGAGGTCTGCTTGCTCGAGAGCCCACACACCAAAATTAGAGAAAGCCCAGGCACAACAACAAACACCCAGCACAGCCAGATAAATAATTTTAAAAAAAGATATCCACTTTAAGTGACAGGAAGAGCAATAAATCCAGCCAAACAAAGTCAACATCTTATCTGTCCACGTGGCTTACGGACTAGGACTTTGGGATCCCATATTCACCTTCTAGTTTCACAGTGACTCCAAGGGGAGGTGCTCCACAGGGTAGGGAGAGGCCCTGAATATGATGAGGGTGAGCCTTGGCTGCCCCTTAGAGTCACCCTTCCCCTACCCCAGACCTCTACCACATCTAGCCTCTGTTTCCTAAAAGGGGATTTTGATACAGAATCTGGTGAGAGCCATTGGGCCCGCTGGCTCACTGGCATCGCCTCACCTCCATCATCCTTTCCCACCCACACAAAACTCTCACAGTGCCCCCTGGAGAAGTCGGTCCATTAGCCCTGGGGCACCACCTCTCACCTTCCTCTCCAACATGGGAGGAACTTGTGTGGAATAACCAAAAGTCTACTACTGTTGGGTCAAGCTCTAACCAATCCAAACCACAGGTTGGGGAGTAGGAGACACAGAAAAGAGGGGCACTGTCCCCCCAAAATGATGAGAACAAAGATGTCCTGGTAGAGACCATGAGTTTTGGAGTCAGACAGACCTGGGTGAGTCCCCACTTCACCACATACTAGCTGTGTGGCTTCAGGAAACATATTTGACCACTCTGAGCCTCAGTTGTCACATCTTTAAAATTGGAATAACATTAATAATACCTCTTTGCATTGTTGCTGTGAGAACTAAATCAAATAATGTATGTGAGGGGTGGTCCCTGGCCTACAGGAGGGACTCCGCTCAGACTCTGGACCCAGACAACTTGGGTTAGAGATCCCTTTAGTGGTTGCGTGACCTTGGCAAGTTACCTCATGTGGCGTTCTCATCTCACATGTGGGTTCACTGGTGTCCTCACAGGGCTGTCGGGAGGATGAGGTCAAGGGTGTGAGACCTTGCCTGGACTTCGTAAGGACTCCGTGAGCCCACGAATTATTTACTAGGTGTGTTCTGACATTGGTGGGTGTGTGTCTCCCGTACCCGGTGGGCCCTGGCATGTGTTTCTGGGATGTGAAGTCAGAGCCTGTTTCCTGGTTGTCGGGAGAGGCTGACCACATTCTACCTATACCTGCCTGTCTAGTTCCTTCTCCCGTTCCTCACCCCACCTCCAAATCTTCCACCCTCTTCATCTCCTGTCCCCCAGCTGCTGTCTGTGACTTTCCCCAGACACCTCTCTGGTAGCCCCCAAGCCTGGGGTTGCAGGGCTACTGGGCTCCGTGGTGTGCCTGGGAGGGGCCTGGGGCTGCCCCCTGAGTAGCCCCGATGTCACCGGAGAAGGCAAGCATTGCGCTGCCCTCGCTCCAACGCGTGTGCACATGCCAGGCAGTCTCGGATGAATCATGTCCACACCGTGCTATTACTAGGCTTGTAACAGAGGCCCTGTGTGCTGGCTTGGGGTATAGTGTTTCTTTCCATTCCATGATTCAGAAAACATCAGTCACTCAGCCATGTGATTCCCTCATCTTCCGCCAAGGAGCTGAGCACAGAGGTTTGCTGGGAAACCCTCAAAGGACAGGGGAGGGCAGCTGTGTGTGGTTGCCAGAAAGGGGATTGAGCTGAGAGAACTGGAAACAGGAACTGGAGAGACTGTCATCAGGAAAAGAGCATCAGGGGACTCAGGTGTGATGAGGCCAGAGCCCTGCCCACGAGAGCAGCTGCTGGCAGATGAAGGGAGCTCACTCAGCTATACACTACCCCAGCCCCAGAAAAAACAATGATTCTTGGGCCTTATTATAAATGTAAAGTTTGCTTATGCAAAATTCTGATCAGCACAGAAAGTTGTAAAAAAGAAAGGACATACCTCTCACATGTTGCTACCAGACACAGTTTTAAATTGTTGGCACACATCTCTGTGCTTGGAACTGCCAGGTTCTGGCCCTCCAAACTACTGACCAGCCGGGGTCTGATCCGGGCTCCTGCCCCAGTCCTCAGGGGACTGTCCTGCCTCAGGGGACACTGAGCTCCAAATGCCCTTGGAGATGGGCCAGGTCTGGGCTCTGGCATCTGGGTTCTAGTCCCAATTTGGTTGTGTGCCCTTAGGCAAATCACTCTGAGTCCTATTTGTGCGGTTACAAATGGAATAATAGGGACTCCCCAGATTGCCCACTGGTTAAGACTCCATGCTCCCAAGGCAGGGGGGCCTGGTTTCAATCCCCGGTCAGGGCACTGAGACCTCACATGCCAGAACTAAGACCCAGGAAAGTGAAAAAGTGAAAGTCGCTCAGTTGTGTCTGACTCTTTGTGATCCCATGGACTCTACTGTCCATGGAATTCTCCAGACCAGAACACTGGAGTGGGTAGCCTTTTCCTTCTCCAGGGGATCTTCCCAACCCTGGGATTGAACCCAGGTCTCCTGCATTGCAGGCAGAGTCTAGACCCAGGGTAGCCAATAAATAAATAAAACAAATATTTTTTAAAAATAGGATAAGAATTGGGCTGATTTGTCCAGAGGATGAAGCATATGAGGGGATATGAAAACTGTAAACCTGCAGAATCTCTTCAAACAGAAGGGGAGGGCCTGCATGATGCCCATTCTCTTGGGGAGGCTCCTTTATCTAGGGGCAGCCTTGAGCCAGCTCTCTTGCTCCACAGCAGAAACTGGTCTGCCCATGTTGACCAAAGGCCTTCCCCCAACCCCGGACTGGCTCAGAGCAGGGAAGCCTCAGTTTGGGATCCCCAGTCATGCCAGTACCACCTCTGAACACCAGTTGAGCACCAGAGTGGGCAGGCACCTGGTTCAGAAAGCTTCAAAACCTTGTTGTGTCGCCAGCTTTGCACCCAGGTAACTGTCTTCCTTTATCTCCCTCACAGATACTGTCACCCCAGCGGGGCCCGTTCTCAGAGCCATCACTGCTCAGAAGCCTCGTTTGATTTCAGGGACCTTTGCGGATGCCCCAAGCGTTGTATCAGTTTACACTGCAGTGATTTGTAGTAAATCCTTGTGTTCTTGTGGAGGGACGGTAATGACAATATAAGACCATTAGATCGGCTATTTCCAAA
SED ID NO:2 sequences are:
CGTTTTCTGTTCTGCGCCGTTACAGATCCAAGCTGTGACCGGCGCCTACTCTGGTACCCTACCACGTGTGGTCAGCTGGAGAGGGCAGTGCCCAGGGAGCTCAGAGCTGCATGCACAGTGTCCCGAGTGCCAGATCAGAAGGGTGAGGAGACGTGGATCAGGCTTCCCCGGCCATCAGACACTGGGGGTGTTGGGGGTCCCAGGAGCACCCCATACCCCAGGAAGTGCTGCTTTCTGAGGGAAAGAGCCCTTGCTGAGGAGTCCAAGGGGCTCTGGTCCCACTCAGCAGCCTGGGACCCCGGGGCCTCAGGTGTCTCTGCCGCTATCAGATCCCTCCTCCTTGGAGTCAACAAGAACCAGCGTGCAGCCAGCTCTGGGCTTCGCAGGGGTTCAGTGGTAAAGAATCTGCCTGCAATGCAGGAGACGTGGGTTCGATCCCTGGGTCGGGAAGATTCCCTGGAGAAGGAAATGGCAACCCACTGCAGTATTCTTGCCTGGAGAATCCCATGGACAGAGGAGTCCAGCGGGCTACAGTCCATGCGGTTGCAAAAGAGTTGAATGTGACTTAGCAACTGAGCACCAACAACAGCCAGTTCTGCACAGACTGTATGACCTCGGGGAAGATGCTGGGCTGTTCCCCACTGGCCCTTCCAGCTCTGTGCCCCGGAAGCTGGCCTAAAGCTGCACTGGTGGGCTCCCTCACCGTCTGGCTTCAGCTGGACGAGAGGAGAATGTGGCCTGGATGCCCTCCCTGCTGGACTGGGGCTTGGCAGTGGCAGATGTCTCTCCCAGAGGCCCTTGGCTCCTCGTGGGCAGCTGTCTCCTCCGGTTACGGCACATACCAGATCCCAGAGGCCTAGAGCGGCAACAGCCCCCTGCTTTGCAGGCTCTGGGTGCCCACCGGCCCTTGTGGGTCCCCCAACTCTGCTCACACGTCTGTACATTGTCTTTTCATCAAGCCCTTCAGCCCCTGTTCTGCATGTGTCTTCTGCCTCTGAACTGCCTGCAATATCACTGAACCCTCTTAGCTTGTTTCCCCATCCTTCTGCTGGGGACCATGATGACATCTGCCTCTAGAAGCTGGAAGAGACAAGGAAACGGATTCTTTCCTAGAGTGATGCAAAGGAACGCTGCTTTGTAGACACCTTGGTTTAGCCCAGACACTGATTTTGGAGATCTGACCTCTGGGCTGTAAGAAGATAAACTTTCGTTGTTTTAAGCCACAACGTTTGTGGCCATTTGTTACAGCGGCCATAGGATACTGCTACACGGGTCCAGGCCCCAGATAAGCAGTGACTGTAATAAATTCTGGGCTCTTCCCCAGCTCCAGCTGAACATTCCAGGAGCAGCTGCTCAGGGGCAACCTGACCGTGACCTCCCAGAACCTCAGTGTCTTCATTTTGGCCTAGGAGGCACATGTGTTTTTTTTTTTTTTCCCCTGCCAGGGTGAAATGCTGACAACAAATTATGTCTCAAGGGTTTCAGACTCCAGTGTTATCAGGAGCCTGAGTAACATGGCAAGTCGCCTGAGTGAGTGGGATGGTGTGAAGCAGTGGGGAGTGGTGGGCCTGTGGCAAACTGGAGAACTCACACCTTGCTTAAAGACATCAACTTTACGACTTCCCCAGCTTCCCTGGTGGCTCAGATGGTAAAGTGTCTGCCTGCAATGCGAGAGACCTGGGTTCGATCCCTGGGTGGAGAAGATCCCCTGGAGAAGGAAATGGAAACCCACTCCAGTACTCTTGCCTGGAAAATTCCATGGACGGAGGAGCCTGGTAGGCTACAGTCCATGGGGTTGCAAAGAGTCAGACAAGACAAAGCGAGTTTGCTTTCACTTTAGGACTTCCCTGGTGGTCCAGTGGTTGAGAATCCACCTGCCAATGGAGGGGACATGGGTTCGATCCCTGGTCAGGGAAGACCCGTGAGGCAGCTGGCCTGCGCACCACCACCACTGAGCCCACGCTCTGGAGCCTGAGCGTTTCAACAGCTGAGGTCTGCTTGCTCGAGAGCCCACACACCAAAATTAGAGAAAGCCCAGGCACAACAACAAACACCCAGCACAGCCAGATAAATAATTTTAAAAAAAGATATCCACTTTAAGTGACAGGAAGAGCAATAAATCCAGCCAAACAAAGTCAACATCTTATCTGTCCACGTGGCTTACGGACTAGGACTTTGGGATCCCATATTCACCTTCTAGTTTCACAGTGACTCCAAGGGGAGGTGCTCCACAGGGTAGGGAGAGGCCCTGAATATGATGAGGGTGAGCCTTGGCTGCCCCTTAGAGTCACCCTTCCCCTACCCCAGACCTCTACCACATCTAGCCTCTGTTTCCTAAAAGGGGATTTTGATACAGAATCTGGTGAGAGCCATTGGGCCCGCTGGCTCACTGGCATCGCCTCACCTCCATCATCCTTTCCCACCCACACAAAACTCTCACAGTGCCCCCTGGAGAAGTCGGTCCATTAGCCCTGGGGCACCACCTCTCACCTTCCTCTCCAACATGGGAGGAACTTGTGTGGAATAACCAAAAGTCTACTACTGTTGGGTCAAGCTCTAACCAATCCAAACCACAGGTTGGGGAGTAGGAGACACAGAAAAGAGGGGCACTGTCCCCCCAAAATGATGAGAACAAAGATGTCCTGGTAGAGACCATGAGTTTTGGAGTCAGACAGACCTGGGTGAGTCCCCACTTCACCACATACTAGCTGTGTGGCTTCAGGAAACATATTTGACCACTCTGAGCCTCAGTTGTCACATCTTTAAAATTGGAATAACATTAATAATACCTCTTTGCATTGTTGCTGTGAGAACTAAATCAAATAATGTATGTGAGGGGTGGTCCCTGGCCTACAGGAGGGACTCCGCTCAGACTCTGGACCCAGACAACTTGGGTTAGAGATCCCTTTAGTGGTTGCGTGACCTTGGCAAGTTACCTCATGTGGCGTTCTCATCTCACATGTGGGTTCACTGGTGTCCTCACAGGGCTGTCGGGAGGATGAGGTCAAGGGTGTGAGACCTTGCCTGGACTTCGTAAGGACTCCGTGAGCCCACGAATTATTTACTAGGTGTGTTCTGACATTGGTGGGTGTGTGTCTCCCGTACCCGGTGGGCCCTGGCATGTGTTTCTGGGATGTGAAGTCAGAGCCTGTTTCCTGGTTGTCGGGAGAGGCTGACCACATTCTACCTATACCTGCCTGTCTAGTTCCTTCTCCCGTTCCTCACCCCACCTCCAAATCTTCCACCCTCTTCATCTCCTGTCCCCCAGCTGCTGTCTGTGACTTTCCCCAGACACCTCTCTGGTAGCCCCCAAGCCTGGGGTTGCAGGGCTACTGGGCTCCGTGGTGTGCCTGGGAGGGGCCTGGGGCTGCCCCCTGAGTAGCCCCGATGTCACCGGAGAAGGCAAGCATTGCGCTGCCCTCGCTCCAACGCGTGTGCACATGCCAGGCAGTCTCGGATGAATCATGTCCACACCGTGCTATTACTAGGCTTGTAACAGAGGCCCTGTGTGCTGGCTTGGGGTATAGTGTTTCTTTCCATTCCATGATTCAGAAAACATCAGTCACTCAGCCATGTGATTCCCTCATCTTCCGCCAAGGAGCTGAGCACAGAGGTTTGCTGGGAAACCCTCAAAGGACAGGGGAGGGCAGCTGTGTGTGGTTGCCAGAAAGGGGATTGAGCTGAGAGAACTGGAAACAGGAACTGGAGAGACTGTCATCAGGAAAAGAGCATCAGGGGACTCAGGTGTGATGAGGCCAGAGCCCTGCCCACGAGAGCAGCTGCTGGCAGATGAAGGGAGCTCACTCAGCTATACACTACCCCAGCCCCAGAAAAAACAATGATTCTTGGGCCTTATTATAAATGTAAAGTTTGCTTATGCAAAATTCTGATCAGCACAGAAAGTTGTAAAAAAGAAAGGACATACCTCTCACATGTTGCTACCAGACACAGTTTTAAATTGTTGGCACACATCTCTGTGCTTGGAACTGCCAGGTTCTGGCCCTCCAAACTACTGACCAGCCGGGGTCTGATCCGGGCTCCTGCCCCAGTCCTCAGGGGACTGTCCTGCCTCAGGGGACACTGAGCTCCAAATGCCCTTGGAGATGGGCCAGGTCTGGGCTCTGGCATCTGGGTTCTAGTCCCAATTTGGTTGTGTGCCCTTAGGCAAATCACTCTGAGTCCTATTTGTGCGGTTACAAATGGAATAATAGGGACTCCCCAGATTGCCCACTGGTTAAGACTCCATGCTCCCAAGGCAGGGGGGCCTGGTTTCAATCCCCGGTCAGGGCACTGAGACCTCACATGCCAGAACTAAGACCCAGGAAAGTGAAAAAGTGAAAGTCGCTCAGTTGTGTCTGACTCTTTGTGATCCCATGGACTCTACTGTCCATGGAATTCTCCAGACCAGAACACTGGAGTGGGTAGCCTTTTCCTTCTCCAGGGGATCTTCCCAACCCTGGGATTGAACCCAGGTCTCCTGCATTGCAGGCAGAGTCTAGACCCAGGGTAGCCAATAAATAAATAAAACAAATATTTTTTAAAAATAGGATAAGAATTGGGCTGATTTGTCCAGAGGATGAAGCATATGAGGGGATATGAAAACTGTAAACCTGCAGAATCTCTTCAAACAGAAGGGGAGGGCCTGCATGATGCCCATTCTCTTGGGGAGGCTCCTTTATCTAGGGGCAGCCTTGAGCCAGCTCTCTTGCTCCACAGCAGAAACTGGTCTGCCCATGTTGACCAAAGGCCTTCCCCCAACCCCGGACTGGCTCAGAGCAGGGAAGCCTCAGTTTGGGATCCCCAGTCATGCCAGTACCACCTCTGAACACCAGTTGAGCACCAGAGTGGGCAGGCACCTGGTTCAGAAAGCTTCAAAACCTTGTTGTGTCGCCAGCTTTGCACCCAGGTAACTGTCTTCCTTTATCTCCCTCACAGATACTGTCACCCCAGCGGGGCCCGTTCTCAGAGCCATCACTGCTCAGAAGCCTCGTTTGATTTCAGGGACCTTTGCGGATGCCCCAAGCGTTGTATCAGTTTACACTGCAGTGATTTGTAGTAAATCCTTGTGTTCTTGTGGAGGGACGGTAATGACAATATAAGACCATTAGATCGGCTATTTCCAAACTCGAGCCTAAGCTTCTAGATAAGATATCCGATCCACCGGATCTAGATAACTGATCATAATCAGCCATACCACATTTGTA.
Claims (2)
1. Use of the briKate black bovine gene LOC112441863 for promoting bovine type ii myofibrilia, characterized in that the use is operated by transfecting a vector comprising a LOC112441863 mimetic or inhibitor into a target cell;
the vector is lentivirus, adenovirus, adeno-associated virus, liposome or plasmid for constructing virus.
2. The use according to claim 1, wherein the target cell is a somatic cell, fertilized egg or cell line of a brisket black cow.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211630814.4A CN116179561B (en) | 2022-12-18 | 2022-12-18 | Application of Braket black cattle skeletal muscle differentiation regulation gene LOC112441863 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202211630814.4A CN116179561B (en) | 2022-12-18 | 2022-12-18 | Application of Braket black cattle skeletal muscle differentiation regulation gene LOC112441863 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116179561A CN116179561A (en) | 2023-05-30 |
CN116179561B true CN116179561B (en) | 2024-06-18 |
Family
ID=86447980
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202211630814.4A Active CN116179561B (en) | 2022-12-18 | 2022-12-18 | Application of Braket black cattle skeletal muscle differentiation regulation gene LOC112441863 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116179561B (en) |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107815496B (en) * | 2017-10-30 | 2020-12-29 | 董雅娟 | Primer for amplifying UCK2 gene of Blackett black cattle, kit and method for screening high-quality Blackett black cattle |
CN110628766B (en) * | 2019-09-23 | 2021-02-02 | 中国农业科学院北京畜牧兽医研究所 | LncRNA coding gene related to sheep skeletal muscle development and application thereof |
KR102453925B1 (en) * | 2020-06-19 | 2022-10-11 | 제주대학교 산학협력단 | Manufacturing method of in vitro meat using satellite cell of jeju black cattle |
CN114480672B (en) * | 2022-02-22 | 2023-08-15 | 青岛农业大学 | Method for screening high-yield carnitine-producing black cows through miR-145 |
-
2022
- 2022-12-18 CN CN202211630814.4A patent/CN116179561B/en active Active
Non-Patent Citations (1)
Title |
---|
Genome-Wide Identification and Characterization of Long Non-Coding RNAs in Longissimus dorsi Skeletal Muscle of Shandong Black Cattle and Luxi Cattle;Ruili Liuet.al.;Frontiers in Genetics;20220516;第13卷;1-13 * |
Also Published As
Publication number | Publication date |
---|---|
CN116179561A (en) | 2023-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105087584B (en) | A kind of miRNA related to chicken abdominal fat sediment and its application | |
CN109182542B (en) | SNP molecular marker related to chicken carcass traits and application thereof | |
CN111154763B (en) | Application of long-chain non-coding RNA lncMGPF in regulation and control of pig muscle development function | |
CN111387105B (en) | Method for producing seeds of all-male macrobrachium rosenbergii | |
CN109234405B (en) | SNP molecular marker related to chicken growth traits and application thereof | |
CN107384931B (en) | Application of FHL3 gene in promoting animal growth | |
CN111560401A (en) | Molecular breeding method for thickening interpuscular spurs of erythroculter ilishaeformis and megalobrama amblycephala | |
CN111549031A (en) | Molecular breeding method for thickening muscle of grass carp and black carp | |
CN105039402B (en) | A kind of method for improveing pig muscle quality | |
CN116179561B (en) | Application of Braket black cattle skeletal muscle differentiation regulation gene LOC112441863 | |
CN107858440A (en) | A kind of SNP marker related to pig birth weight character and application thereof | |
CN114480672B (en) | Method for screening high-yield carnitine-producing black cows through miR-145 | |
CN106350519A (en) | MicroRNA for adjusting rapid growth of cornua cervi pantotrichum cartilage and application thereof | |
CN106244593A (en) | A kind of microRNA regulating Cornu Cervi Pantotrichum young pilose antler skin fast-growth and application thereof | |
CN109402269A (en) | One kind miRNA relevant to duck enteron aisle oxidative stress and its application | |
CN114891796A (en) | Application of miRNA-133 in regulating development of sheep embryo hair follicle | |
CN114854882A (en) | Sheep hair follicle development marker miR-23b and application thereof | |
Thu et al. | Phylogenetic analysis of subgroup J avian leucosis virus from broiler and native chickens in Taiwan during 2000-2002 | |
CN109563512A (en) | For treating the truncation Dysferlin of Dysferlin myopathy | |
Atanassov et al. | Mitochondrial control region DNA variation in turbot populations from the Bulgarian and Romanian Black Sea coasts | |
CN102703506A (en) | Alpha 1,2-fucosyltransferase gene silenced somatic cloning pig, as well production method and application thereof | |
CN105969745A (en) | Fish hypoxia-tolerance gene and application thereof | |
CN112574996B (en) | Long-chain non-coding RNA AAGNCR and application thereof | |
CN113801948B (en) | SNP locus for genetically improving chicken growth traits and application thereof | |
CN109964860A (en) | A method of promoting lefteye flounder spermary apoptosis of germ cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |